Sudhanshu Vrati
NCR Biotech Science Cluster, Faridabad Gurugram Expressway
Faridabad, HR 121001, India
Faridabad, HR 121001, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications
Ewing sarcoma breakpoint region 1 (EWSR1) protein binds to nonstructural protein 2 and non-coding regions of chikungunya virus genome to inhibit virus replication.
Journal: Journal of virology
Published: July 21, 2026
Emetine dihydrochloride inhibits Chikungunya virus nsP2 helicase and shows robust antiviral activity in cells and mice.
Journal: Journal of biomedical science
Published: July 13, 2026
Molecular insights into the anti-COVID-19 activity of reduced (quinol) and oxidized (quinone) forms of coenzyme Q10.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: April 09, 2026
AGPAT1 is a novel Chikungunya virus receptor on human cells.
Journal: Journal of virology
Published: February 17, 2026
Current perspectives on alphavirus encapsidation, assembly and budding.
Journal: Frontiers in cellular and infection microbiology
Published: October 07, 2025
Endophilin mediated endocytosis and epidermal growth factor receptor govern Japanese encephalitis virus entry and infection in neuronal cells.
Journal: PLoS pathogens
Published: May 12, 2025
Corticosteroid Prednisolone and flavonoid Chrysin as drug candidates against SARS-CoV-2 replication: Computational and experimental findings.
Journal: Microbial pathogenesis
Published: April 25, 2025
Targeting Two-Tetrad RNA G-Quadruplex in the SARS-CoV-2 RNA Genome Using Tetraphenylethene Derivatives for Antiviral Therapy.
Journal: ACS infectious diseases
Published: February 28, 2025
Identification and profiling of novel metagenome assembled uncultivated virus genomes from human gut.
Journal: Virology journal
Published: October 16, 2024
Japanese encephalitis virus NS5 protein interacts with nucleolin to enhance the virus replication.
Journal: Journal of virology
Published: July 30, 2024
Psoralidin acts as a dual protease inhibitor against PLpro and Mpro of SARS-CoV-2.
Journal: The FEBS journal
Published: July 24, 2024
Withaferin A inhibits Chikungunya virus nsP2 protease and shows antiviral activity in the cell culture and mouse model of virus infection.
Journal: PLoS pathogens
Published: May 09, 2024
Last Updated: 09/26/2026